i&i Biotech Fund (i&i Bio) is a Luxembourg-based venture capital fund focused on innovative European life science companies in drug discovery, medtech, diagnostics, and AI. Established in 2021 in cooperation with the European Investment Fund (EIF) and i&i Prague, it manages over €53M and invests in early-stage biotech ventures.
65% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $2.7M (across 4 rounds with reported amounts).
Portfolio
12
Fund Size
$57M
Top Stage
Series A
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
17 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Ternary Therapeutics | Seed | — | Jan 2026 |
 KyDo Therapeutics | Seed | — | Sep 2025 |
| IiQure Pharma | Unknown | $4M | Jan 2025 |
 CasInvent | Series A | — | Jan 2024 |
 HeartBeat.bio | Seed | — | Nov 2023 |
| HeartBeat.bio | Series A | — | Nov 2023 |
 Delta Life Science | Series A | — | May 2023 |
 iQure | Unknown | $1.2M | Jan 2023 |
 Enzyre | Series A | — | Nov 2022 |
| CasInvent | Series A | — | Sep 2022 |
| Delta Life Science | Seed | — | Jan 2022 |
| CasInvent | Pre-Seed | $1.2M | Jan 2022 |
 Nanoligent | Series A | — | — |
 Theorema | Pre-Seed | — | — |
| CCeleris | Seed | $4.4M | — |
 Sophomer | Unknown | — | — |
| Nanoligent | Seed | — | — |
Top Co-Investors
Oost NL2 shared
Angel Invest2 shared
Banco Sabadell2 shared
PhotonDelta2 shared
Takeda Ventures, Inc.1 shared
Exor Ventures1 shared
CDTI1 shared
Inveready1 shared
Kaya VC1 shared
Credo Ventures1 shared
Amino Collective1 shared
Keiretsu Forum1 shared
APEX Ventures1 shared
Amadeus APEX Technology Fund1 shared
InnovationQuarter1 shared
Future Planet Capital1 shared
Daphni1 shared
Desert Angels1 shared
Last updated: 20 October 2026